Immunotherapy in Advanced Non-small Cell Lung Cancer Patients: Ushering Chemotherapy Through the Checkpoint Inhibitors?

New ways of exploiting the immune system for cancer treatment have been tested for decades with moderate outcomes. Based on previous immunotherapy knowledge, agents targeting immune checkpoints seem to be remarkably effective in a wide range of tumors. Immune checkpoint inhibitors in metastatic non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwal, Bushra, Biswas, Sharmi, Seminara, Robert S, Jeet, Charan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217867/
https://www.ncbi.nlm.nih.gov/pubmed/30416904
http://dx.doi.org/10.7759/cureus.3254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217867/
https://www.ncbi.nlm.nih.gov/pubmed/30416904
http://dx.doi.org/10.7759/cureus.3254

Ejemplares similares